{"id":"https://openalex.org/W7204969338","doi":"https://doi.org/10.1158/0008-5472.can-25-5580","title":"The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity","display_name":"The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity","publication_year":2026,"publication_date":"2026-09-01","ids":{"openalex":"https://openalex.org/W7204969338","doi":"https://doi.org/10.1158/0008-5472.can-25-5580","pmid":"https://pubmed.ncbi.nlm.nih.gov/42678245"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-25-5580","doi":"https://doi.org/10.1158/0008-5472.can-25-5580","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-25-5580","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5148893911","display_name":"Jia Liu","orcid":"https://orcid.org/0009-0005-9910-8891","observed_orcids":["https://orcid.org/0009-0005-9910-8891"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jia Liu","raw_affiliation_strings":["1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0005-9910-8891","affiliations":[{"raw_affiliation_string":"1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102846037","display_name":"Jingbo Ma","orcid":"https://orcid.org/0009-0007-6625-984X","observed_orcids":["https://orcid.org/0009-0007-6625-984X","https://orcid.org/0000-0003-0101-0318"]},"institutions":[{"id":"https://openalex.org/I159948400","display_name":"Jinan University","ror":"https://ror.org/02xe5ns62","country_code":"CN","type":"education","lineage":["https://openalex.org/I159948400"]},{"id":"https://openalex.org/I3045169105","display_name":"Southern University of Science and Technology","ror":"https://ror.org/049tv2d57","country_code":"CN","type":"education","lineage":["https://openalex.org/I3045169105"]},{"id":"https://openalex.org/I4210105608","display_name":"ShenZhen People\u2019s Hospital","ror":"https://ror.org/01hcefx46","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105608"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jingbo Ma","raw_affiliation_strings":["Shenzhen People\u2019s Hospital 2 Department of Hematology, Guangdong Provincial Clinical Research Center for Geriatrics, (The First Affiliated Hospital, Southern University of Science and Technology, The Second Clinical Medical College, Jinan University), Shenzhen, China"],"raw_orcid":"https://orcid.org/0009-0007-6625-984X","affiliations":[{"raw_affiliation_string":"Shenzhen People\u2019s Hospital 2 Department of Hematology, Guangdong Provincial Clinical Research Center for Geriatrics, (The First Affiliated Hospital, Southern University of Science and Technology, The Second Clinical Medical College, Jinan University), Shenzhen, China","institution_ids":["https://openalex.org/I159948400","https://openalex.org/I3045169105","https://openalex.org/I4210105608"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101328894","display_name":"Shuming Lin","orcid":"https://orcid.org/0009-0005-8715-9026","observed_orcids":["https://orcid.org/0009-0005-8715-9026"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuming Lin","raw_affiliation_strings":["1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0005-8715-9026","affiliations":[{"raw_affiliation_string":"1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5133854207","display_name":"Wei Dai","orcid":"https://orcid.org/0009-0006-1935-2868","observed_orcids":["https://orcid.org/0009-0006-1935-2868"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei Dai","raw_affiliation_strings":["1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0006-1935-2868","affiliations":[{"raw_affiliation_string":"1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5126737899","display_name":"Jia Lu","orcid":"https://orcid.org/0009-0000-8012-2988","observed_orcids":["https://orcid.org/0009-0000-8012-2988"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jia Lu","raw_affiliation_strings":["3Department of Pharmacology and Toxicology, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0000-8012-2988","affiliations":[{"raw_affiliation_string":"3Department of Pharmacology and Toxicology, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Min Wu","orcid":"https://orcid.org/0009-0003-2053-7948","observed_orcids":["https://orcid.org/0009-0003-2053-7948"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Min Wu","raw_affiliation_strings":["3Department of Pharmacology and Toxicology, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0003-2053-7948","affiliations":[{"raw_affiliation_string":"3Department of Pharmacology and Toxicology, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148872541","display_name":"Yifan Wang","orcid":"https://orcid.org/0009-0007-2920-513X","observed_orcids":["https://orcid.org/0009-0007-2920-513X"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yifan Wang","raw_affiliation_strings":["1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0007-2920-513X","affiliations":[{"raw_affiliation_string":"1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103223354","display_name":"Huilin Zheng","orcid":"https://orcid.org/0000-0003-3845-6612","observed_orcids":["https://orcid.org/0000-0003-3845-6612","https://orcid.org/0009-0005-9763-1275"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huilin Zheng","raw_affiliation_strings":["1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0005-9763-1275","affiliations":[{"raw_affiliation_string":"1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050659832","display_name":"Shuaixiang Zhou","orcid":"https://orcid.org/0009-0003-6167-3241","observed_orcids":["https://orcid.org/0009-0003-6167-3241","https://orcid.org/0009-0005-5272-2202"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuaixiang Zhou","raw_affiliation_strings":["4Department of Antibody Discovery and Protein Engineering, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0005-5272-2202","affiliations":[{"raw_affiliation_string":"4Department of Antibody Discovery and Protein Engineering, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121820719","display_name":"Yang Liu","orcid":"https://orcid.org/0009-0006-0866-8808","observed_orcids":["https://orcid.org/0009-0006-0866-8808"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yang Liu","raw_affiliation_strings":["3Department of Pharmacology and Toxicology, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0006-0866-8808","affiliations":[{"raw_affiliation_string":"3Department of Pharmacology and Toxicology, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148903225","display_name":"Feifei Wang","orcid":"https://orcid.org/0009-0008-2206-0465","observed_orcids":["https://orcid.org/0009-0008-2206-0465"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Feifei Wang","raw_affiliation_strings":["4Department of Antibody Discovery and Protein Engineering, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0008-2206-0465","affiliations":[{"raw_affiliation_string":"4Department of Antibody Discovery and Protein Engineering, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100365144","display_name":"Bin Li","orcid":"https://orcid.org/0000-0002-1147-3992","observed_orcids":["https://orcid.org/0000-0002-1147-3992"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Bin Li","raw_affiliation_strings":["4Department of Antibody Discovery and Protein Engineering, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0000-0002-1147-3992","affiliations":[{"raw_affiliation_string":"4Department of Antibody Discovery and Protein Engineering, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031764239","display_name":"Zhihai Wu","orcid":"https://orcid.org/0000-0001-7293-9250","observed_orcids":["https://orcid.org/0000-0001-7293-9250"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhihai Wu","raw_affiliation_strings":["4Department of Antibody Discovery and Protein Engineering, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0000-0001-7293-9250","affiliations":[{"raw_affiliation_string":"4Department of Antibody Discovery and Protein Engineering, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148835325","display_name":"Wangwang Liu","orcid":"https://orcid.org/0009-0002-8210-071X","observed_orcids":["https://orcid.org/0009-0002-8210-071X"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wangwang Liu","raw_affiliation_strings":["3Department of Pharmacology and Toxicology, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0002-8210-071X","affiliations":[{"raw_affiliation_string":"3Department of Pharmacology and Toxicology, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148880540","display_name":"Jing Lyu","orcid":"https://orcid.org/0009-0000-8068-8578","observed_orcids":["https://orcid.org/0009-0000-8068-8578"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jing Lyu","raw_affiliation_strings":["4Department of Antibody Discovery and Protein Engineering, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0000-8068-8578","affiliations":[{"raw_affiliation_string":"4Department of Antibody Discovery and Protein Engineering, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yayao Yan","orcid":"https://orcid.org/0009-0004-1563-7220","observed_orcids":["https://orcid.org/0009-0004-1563-7220"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yayao Yan","raw_affiliation_strings":["3Department of Pharmacology and Toxicology, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0004-1563-7220","affiliations":[{"raw_affiliation_string":"3Department of Pharmacology and Toxicology, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148941573","display_name":"Jinling Xu","orcid":"https://orcid.org/0009-0008-1561-0908","observed_orcids":["https://orcid.org/0009-0008-1561-0908"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jinling Xu","raw_affiliation_strings":["3Department of Pharmacology and Toxicology, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0008-1561-0908","affiliations":[{"raw_affiliation_string":"3Department of Pharmacology and Toxicology, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148873597","display_name":"Jian Guan","orcid":"https://orcid.org/0009-0000-1113-503X","observed_orcids":["https://orcid.org/0009-0000-1113-503X"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jian Guan","raw_affiliation_strings":["1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0000-1113-503X","affiliations":[{"raw_affiliation_string":"1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018295220","display_name":"Liang-Yong Xia","orcid":"https://orcid.org/0000-0003-1015-7127","observed_orcids":["https://orcid.org/0000-0003-1015-7127"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Liangyong Xia","raw_affiliation_strings":["4Department of Antibody Discovery and Protein Engineering, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0000-0003-1015-7127","affiliations":[{"raw_affiliation_string":"4Department of Antibody Discovery and Protein Engineering, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090067222","display_name":"Huisi Liu","orcid":"https://orcid.org/0009-0003-2749-3343","observed_orcids":["https://orcid.org/0009-0003-2749-3343"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huisi Liu","raw_affiliation_strings":["4Department of Antibody Discovery and Protein Engineering, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0009-0003-2749-3343","affiliations":[{"raw_affiliation_string":"4Department of Antibody Discovery and Protein Engineering, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017445578","display_name":"Yuanqiao He","orcid":"https://orcid.org/0000-0001-8974-4273","observed_orcids":["https://orcid.org/0000-0001-8974-4273"]},"institutions":[{"id":"https://openalex.org/I141649914","display_name":"Nanchang University","ror":"https://ror.org/042v6xz23","country_code":"CN","type":"education","lineage":["https://openalex.org/I141649914"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuanqiao He","raw_affiliation_strings":["6Key Laboratory of New Drug Evaluation and Transformation of Jiangxi Province, Nanchang, China","Nanchang University 5 Center of Laboratory Animal Science, , Nanchang, China"],"raw_orcid":"https://orcid.org/0000-0001-8974-4273","affiliations":[{"raw_affiliation_string":"6Key Laboratory of New Drug Evaluation and Transformation of Jiangxi Province, Nanchang, China","institution_ids":[]},{"raw_affiliation_string":"Nanchang University 5 Center of Laboratory Animal Science, , Nanchang, China","institution_ids":["https://openalex.org/I141649914"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018101112","display_name":"Jihao Zhou","orcid":"https://orcid.org/0000-0002-2684-192X","observed_orcids":["https://orcid.org/0000-0002-2684-192X"]},"institutions":[{"id":"https://openalex.org/I159948400","display_name":"Jinan University","ror":"https://ror.org/02xe5ns62","country_code":"CN","type":"education","lineage":["https://openalex.org/I159948400"]},{"id":"https://openalex.org/I3045169105","display_name":"Southern University of Science and Technology","ror":"https://ror.org/049tv2d57","country_code":"CN","type":"education","lineage":["https://openalex.org/I3045169105"]},{"id":"https://openalex.org/I4210105608","display_name":"ShenZhen People\u2019s Hospital","ror":"https://ror.org/01hcefx46","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105608"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jihao Zhou","raw_affiliation_strings":["Shenzhen People\u2019s Hospital 7 Department of Hematology, (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China"],"raw_orcid":"https://orcid.org/0000-0002-2684-192X","affiliations":[{"raw_affiliation_string":"Shenzhen People\u2019s Hospital 7 Department of Hematology, (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China","institution_ids":["https://openalex.org/I159948400","https://openalex.org/I3045169105","https://openalex.org/I4210105608"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025953259","display_name":"Kaijie He","orcid":"https://orcid.org/0000-0001-8866-1994","observed_orcids":["https://orcid.org/0000-0001-8866-1994"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Kaijie He","raw_affiliation_strings":["1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0000-0001-8866-1994","affiliations":[{"raw_affiliation_string":"1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100341910","display_name":"Zhijie Li","orcid":"https://orcid.org/0000-0002-5445-7976","observed_orcids":["https://orcid.org/0000-0002-5445-7976","https://orcid.org/0000-0003-4362-5652","https://orcid.org/0000-0001-7096-2158","https://orcid.org/0000-0002-2639-0698","https://orcid.org/0000-0003-1561-3435","https://orcid.org/0009-0002-6973-3782","https://orcid.org/0009-0003-9337-0675","https://orcid.org/0000-0003-1630-0668"]},"institutions":[{"id":"https://openalex.org/I159948400","display_name":"Jinan University","ror":"https://ror.org/02xe5ns62","country_code":"CN","type":"education","lineage":["https://openalex.org/I159948400"]},{"id":"https://openalex.org/I3045169105","display_name":"Southern University of Science and Technology","ror":"https://ror.org/049tv2d57","country_code":"CN","type":"education","lineage":["https://openalex.org/I3045169105"]},{"id":"https://openalex.org/I4210105608","display_name":"ShenZhen People\u2019s Hospital","ror":"https://ror.org/01hcefx46","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210105608"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhijie Li","raw_affiliation_strings":["Shenzhen People\u2019s Hospital 2 Department of Hematology, Guangdong Provincial Clinical Research Center for Geriatrics, (The First Affiliated Hospital, Southern University of Science and Technology, The Second Clinical Medical College, Jinan University), Shenzhen, China"],"raw_orcid":"https://orcid.org/0000-0002-5445-7976","affiliations":[{"raw_affiliation_string":"Shenzhen People\u2019s Hospital 2 Department of Hematology, Guangdong Provincial Clinical Research Center for Geriatrics, (The First Affiliated Hospital, Southern University of Science and Technology, The Second Clinical Medical College, Jinan University), Shenzhen, China","institution_ids":["https://openalex.org/I159948400","https://openalex.org/I3045169105","https://openalex.org/I4210105608"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079823537","display_name":"Tiongsun Chia","orcid":"https://orcid.org/0000-0002-7328-6615","observed_orcids":["https://orcid.org/0000-0002-7328-6615"]},"institutions":[{"id":"https://openalex.org/I4405270994","display_name":"Innovent Biologics (China)","ror":"https://ror.org/01p82gg75","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405270994"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Tiongsun Chia","raw_affiliation_strings":["1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China"],"raw_orcid":"https://orcid.org/0000-0002-7328-6615","affiliations":[{"raw_affiliation_string":"1Department of Cancer Biology, Innovent Guoqing Academy, Suzhou, China","institution_ids":["https://openalex.org/I4405270994"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5079823537"],"corresponding_institution_ids":["https://openalex.org/I4405270994"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"OF1","last_page":"OF18"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9603999853134155,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.014499999582767487,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trispecific-antibodies","display_name":"trispecific antibodies","score":0.8849999904632568},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.8989999890327454},{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.6600000262260437},{"id":"https://openalex.org/keywords/cdh17","display_name":"CDH17","score":0.949999988079071},{"id":"https://openalex.org/keywords/fcgammariiia","display_name":"Fc\u03b3RIIIa","score":0.8220000267028809},{"id":"https://openalex.org/keywords/nk-cell-engagers","display_name":"NK cell engagers","score":0.843999981880188},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.7490000128746033},{"id":"https://openalex.org/keywords/immunological-synapse","display_name":"immunological synapse","score":0.9620000123977661},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.8339999914169312},{"id":"https://openalex.org/keywords/amivantamab","display_name":"amivantamab","score":0.9819999933242798},{"id":"https://openalex.org/keywords/on-target-off-tumor-toxicity","display_name":"on-target off-tumor toxicity","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.675000011920929},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.6238999962806702},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.6090999841690063},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5350000262260437},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5189999938011169},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5181000232696533},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.51419997215271},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4846000075340271},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47110000252723694},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4189999997615814},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39820000529289246},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.3230000138282776},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.3140000104904175},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.31209999322891235},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.30640000104904175},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.298799991607666},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2973000109195709},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.295199990272522},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.2924000024795532},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.2831000089645386},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2736999988555908},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2736999988555908},{"id":"https://openalex.org/C125823703","wikidata":"https://www.wikidata.org/wiki/Q1616930","display_name":"Fragment crystallizable region","level":3,"score":0.2687000036239624},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2687000036239624},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.2651999890804291},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.26339998841285706},{"id":"https://openalex.org/C2777383412","wikidata":"https://www.wikidata.org/wiki/Q4770891","display_name":"Antagonism","level":3,"score":0.2612999975681305},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.25870001316070557},{"id":"https://openalex.org/C26375932","wikidata":"https://www.wikidata.org/wiki/Q118226","display_name":"Growth factor receptor","level":3,"score":0.25839999318122864},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.25529998540878296},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2542000114917755}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.can-25-5580","doi":"https://doi.org/10.1158/0008-5472.can-25-5580","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-25-5580","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:42678245","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42678245","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320317608","display_name":"Innovent Biologics","ror":"https://ror.org/01p82gg75"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409652763","https://openalex.org/W349287760","https://openalex.org/W2795397263","https://openalex.org/W2740484700","https://openalex.org/W3186443242","https://openalex.org/W2892326030","https://openalex.org/W4393988321","https://openalex.org/W2887333630","https://openalex.org/W2051221116","https://openalex.org/W1993981778"],"abstract_inverted_index":{"Potent":[0],"and":[1,30,40,55,92,102,112,151,168,219],"sustained":[2,104],"inhibition":[3,60],"of":[4,84,106,116,240],"epidermal":[5],"growth":[6,59],"factor":[7],"receptor":[8],"(EGFR)":[9],"signaling":[10],"is":[11,139],"critical":[12],"for":[13,208],"suppressing":[14],"colorectal":[15],"cancer":[16],"(CRC)":[17],"growth,":[18],"yet":[19],"current":[20],"EGFR":[21,28,39,108,203],"therapies":[22],"are":[23],"often":[24],"limited":[25],"by":[26,51,142],"incomplete":[27],"blockade":[29,204],"on-target/off-tumor":[31],"toxicities,":[32],"particularly":[33],"skin":[34,230],"rash.":[35],"Here,":[36],"we":[37],"co-targeted":[38],"cadherin-17":[41],"(CDH17)":[42],"with":[43,155,185,205,227],"a":[44,125,195,220],"bispecific":[45],"antibody":[46,179,198],"(bsAb),":[47],"overcoming":[48],"these":[49],"limitations":[50],"reducing":[52],"skin-related":[53],"toxicities":[54],"achieving":[56],"superior":[57,101,215],"tumor":[58,78,148],"compared":[61,182],"to":[62,76,99,170,183],"EGFR-":[63],"or":[64,86],"c-MET/EGFR-targeting":[65],"antibodies.":[66],"Mechanistically,":[67],"the":[68,73,77,96,107,121,143,147,152,159,165,175,237],"high-affinity":[69],"CDH17-binding":[70],"arm":[71],"anchored":[72],"EGFR/CDH17":[74,97,122],"bsAb":[75,98,123],"cell":[79,137,211],"surface,":[80],"facilitating":[81],"rapid":[82],"engagement":[83],"unbound":[85],"newly":[87],"synthesized":[88],"EGFR.":[89],"This":[90],"\"anchor":[91],"capture\"":[93],"mechanism":[94],"allowed":[95],"achieve":[100],"more":[103],"suppression":[105],"pathway":[109],"than":[110],"cetuximab":[111],"amivantamab.":[113],"Further":[114],"incorporation":[115],"an":[117],"anti-CD16A":[118,153],"nanobody":[119],"transformed":[120],"into":[124],"trispecific":[126,197],"natural":[127],"killer":[128],"(NK)-cell":[129],"engager.":[130],"Extensive":[131],"format":[132],"screening":[133],"revealed":[134],"that":[135,199],"NK":[136,210],"activation":[138],"heavily":[140],"influenced":[141],"spatial":[144],"distance":[145],"between":[146],"antigen-binding":[149],"Fab":[150],"nanobody,":[154],"longer":[156],"distances":[157],"impairing":[158],"bulky":[160],"CD45":[161],"phosphatase":[162],"exclusion":[163],"from":[164],"immunological":[166],"synapse":[167],"leading":[169],"significantly":[171],"reduced":[172],"cytotoxicity.":[173],"Consequently,":[174],"widely":[176],"adopted":[177],"Morrison-type":[178],"consistently":[180],"underperformed":[181],"architectures":[184],"shorter":[186],"CD16A-TAA-Fab":[187],"spacing.":[188],"The":[189],"final":[190],"optimized":[191],"molecule":[192],"was":[193],"IBI3019,":[194],"CDH17/EGFR/CD16A":[196],"integrates":[200],"potent":[201],"CDH17-enhanced":[202],"optimal":[206],"architecture":[207],"efficient":[209],"engagement.":[212],"It":[213],"demonstrated":[214],"in":[216,224],"vivo":[217],"efficacy":[218],"good":[221],"safety":[222],"profile":[223],"cynomolgus":[225],"monkeys,":[226],"no":[228],"observable":[229],"toxicity.":[231],"These":[232],"promising":[233],"pre-clinical":[234],"findings":[235],"warrant":[236],"clinical":[238],"development":[239],"IBI3019.":[241],".":[242]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-09-02T00:00:00"}